Clinical Trial Update: A Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating ABP1011T tablets for small cell lung cancer and other advanced solid tumors; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• ABP1011T Tablets

Snippet

Sponsor: Shanghai AB PharmaTech Ltd. | Conditions: SCLC, Extensive Stage, Advanced Solid Tumors | Phase 2 | Status: RECRUITING